You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 021201


✉ Email this page to a colleague

« Back to Dashboard


NDA 021201 describes ASCLERA, which is a drug marketed by Chemisch Fbrk Krsslr and is included in one NDA. It is available from one supplier. Additional details are available on the ASCLERA profile page.

The generic ingredient in ASCLERA is polidocanol. Two suppliers are listed for this compound. Additional details are available on the polidocanol profile page.
Summary for 021201
Tradename:ASCLERA
Applicant:Chemisch Fbrk Krsslr
Ingredient:polidocanol
Patents:0
Pharmacology for NDA: 021201
Mechanism of ActionSclerosing Activity
Physiological EffectVascular Sclerosing Activity
Suppliers and Packaging for NDA: 021201
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ASCLERA polidocanol SOLUTION;INTRAVENOUS 021201 NDA Methapharm, Inc 67850-140 67850-140-05 2 mL in 1 AMPULE (67850-140-05)
ASCLERA polidocanol SOLUTION;INTRAVENOUS 021201 NDA Methapharm, Inc 67850-141 67850-141-05 2 mL in 1 AMPULE (67850-141-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength10MG/2ML (5MG/ML)
Approval Date:Mar 30, 2010TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength20MG/2ML (10MG/ML)
Approval Date:Mar 30, 2010TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.